Abbott MediaRoom https://stage.mediaroom.com/abbott/ Abbott declares 410th consecutive quarterly dividend https://stage.mediaroom.com/abbott/2026-06-12-Abbott-declares-410th-consecutive-quarterly-dividend Fri, 12 Jun 2026 14:29:00 -0400 https://stage.mediaroom.com/abbott/2026-06-12-Abbott-declares-410th-consecutive-quarterly-dividend New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers https://stage.mediaroom.com/abbott/2026-06-08-New-research-shows-even-stronger-health-outcomes-for-participants-in-a-Food-is-Medicine-program-when-paired-with-support-from-community-health-workers Mon, 08 Jun 2026 09:00:00 -0400 https://stage.mediaroom.com/abbott/2026-06-08-New-research-shows-even-stronger-health-outcomes-for-participants-in-a-Food-is-Medicine-program-when-paired-with-support-from-community-health-workers New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis https://stage.mediaroom.com/abbott/2026-06-06-New-Abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis Sat, 06 Jun 2026 09:00:00 -0400 https://stage.mediaroom.com/abbott/2026-06-06-New-Abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes https://stage.mediaroom.com/abbott/2026-05-27-Abbott-secures-CE-Mark-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes Wed, 27 May 2026 09:00:00 -0400 https://stage.mediaroom.com/abbott/2026-05-27-Abbott-secures-CE-Mark-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening https://stage.mediaroom.com/abbott/2026-05-27-ACS-guideline-reaffirms-Abbott-leadership-in-noninvasive-colorectal-cancer-screening Wed, 27 May 2026 07:01:00 -0400 https://stage.mediaroom.com/abbott/2026-05-27-ACS-guideline-reaffirms-Abbott-leadership-in-noninvasive-colorectal-cancer-screening